General Knowledge MCQs
Topic Notes: General Knowledge
MCQs and preparation resources for competitive exams, covering important concepts, past papers, and detailed explanations.
Plato
- Biography: Ancient Greek philosopher (427–347 BCE), student of Socrates and teacher of Aristotle, founder of the Academy in Athens.
- Important Ideas:
- Theory of Forms
- Philosopher-King
- Ideal State
3091
Researchers at St. Jude Children's Research Hospital launched which database in November 2025 to keep protein structure predictions up to date?
Answer:
AlphaSync
St. Jude scientists launched the AlphaSync database in November 2025. This resource is designed to keep protein structure predictions current, helping to prevent cascading errors in research that relies on outdated models.
3092
Which company was acquired by Amazon to bolster its AI wearable technology, specifically known for a wristband called 'Bee'?
Answer:
Bee
Reports in 2025 indicated that Amazon acquired the startup 'Bee', known for its AI wearable wristband, to integrate its ambient intelligence capabilities into Amazon's product ecosystem.
3093
What type of robot, often referred to as a 'MoMa', became a significant trend in industrial robotics in 2025?
Answer:
Mobile Manipulator
Mobile Manipulators, or 'MoMas', emerged as a major trend in 2025. They combine a robotic arm with a mobile base (AMR), allowing the robot to move around a facility and perform complex handling tasks at different locations.
3094
A November 2025 study indicated that combining Tirzepatide and Semaglutide provided strong protection against which major health event?
Answer:
Heart attack and stroke
A massive real-world study in November 2025 revealed that both Tirzepatide and Semaglutide (GLP-1 drugs) deliver strong cardiovascular protection, significantly reducing the risk of heart attack, stroke, and death in adults with type 2 diabetes.
3095
Which drug received FDA approval in September 2025 for the treatment of chronic spontaneous urticaria?
Answer:
Rhapsido (remibrutinib)
Rhapsido (remibrutinib) was approved by the FDA in September 2025 for treating chronic spontaneous urticaria in adults who remain symptomatic despite antihistamine treatment.
3096
In November 2025, a study found that which common amino acid supplement could significantly reduce amyloid-beta aggregation in Alzheimer's disease models?
Answer:
Arginine
A study published in November 2025 discovered that the amino acid arginine can block harmful amyloid-beta aggregation and reduce its toxic effects in Alzheimer's disease models, suggesting a potential simple therapeutic intervention.
3097
Researchers in November 2025 created a 'miniature' version of which human body system to study blood production and diseases like leukemia?
Answer:
Bone Marrow
Scientists successfully engineered a miniature human bone marrow system in the lab in November 2025. This organoid mirrors the real structure of bone marrow and supports blood cell production, providing a new model for studying blood diseases.
3098
Which tool, described in Nature Communications in 2025, uses AI to identify relevant clinical trials for patients and explain their eligibility?
Answer:
TrialGPT
TrialGPT is an AI algorithm highlighted in 2025 that successfully identifies relevant clinical trials for patients and provides summaries explaining how they meet the enrollment criteria, facilitating better access to experimental treatments.
3099
What is the primary function of the drug 'Lynkuet' (elinzanetant), which was approved by the FDA in October 2025?
Answer:
Treating vasomotor symptoms of menopause
Lynkuet (elinzanetant) was approved in October 2025 as a non-hormonal treatment for moderate-to-severe vasomotor symptoms, commonly known as hot flashes, associated with menopause.
3100
In September 2025, West Virginia University scientists successfully used AI to detect which condition in rural patients using low-tech ECG data?
Answer:
Heart Failure
Scientists at West Virginia University developed AI models that could detect signs of heart failure using simple ECG data, significantly improving early diagnosis rates for underserved rural populations.